# Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension

> **NCT00060931** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 501 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** carvedilol
- **DRUG:** metoprolol

## Key facts

- **NCT ID:** NCT00060931
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060931, "Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00060931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*